surmount study tirzepatide SURMOUNT‐1 design. This is a phase 3, multicenter, randomized, Tirzepatide for the treatment of
Description
GLP-1 drugs impact digestion and appetite

By working with Novo Nordisk, starting today through Ro, patients can get their first month of FDA-approved Wegovy for $199 plus their first month of the Ro Body membership for just $45

Serving The Woodlands, TX

By using integrated technology platforms and tapping into the increased use of wearable technology, patients can participate more actively in their healthcare
Experience better mitochondrial function, brain health, and youthful vitality today!

Lab-led titration, branded options, concierge cadence not a quiz funnel.
